-+ 0.00%
-+ 0.00%
-+ 0.00%

Genprex Presents Diabetes Gene Therapy Delivery Strategy at Future of Cell and Gene Therapy Symposium

PUBT·11/11/2026 12:01:23
Listen to the news
Genprex Presents Diabetes Gene Therapy Delivery Strategy at Future of Cell and Gene Therapy Symposium
  • Genprex will present its dual-delivery diabetes gene therapy strategy at the virtual Future of Cell and Gene Therapy Symposium, Nov. 17-18, 2026.
  • Pier-Anne Lachance, senior director of quality control and product development, will discuss AAV-based and nonviral lipid-based approaches, both in preclinical development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genprex Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202611110700PR_NEWS_USPR_____DA94388) on November 11, 2026, and is solely responsible for the information contained therein.